Premium Information is available for this item - Upgrade for $1 a day
6505-01-074-0985
Usp Prochlorperazine Edisylate Injection
6505010740985 010740985 NDC0007-3351-01 COMPAZINE INJECTION
June 2023
5
Marketplace 6505-01-074-0985
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-074-0985 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-074-0985 RQST Updated Every Day 6505-01-074-0985 RQST NE Related Documents
6505-01-074-0985 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-074-0985
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-656-1610 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-074-0985
NDC0007-3351-01 COMPAZINE Usp Prochlorperazine Edisylate Injection Related Documents 6505-00-656-1610
To Not Yet AvailNOT YET AVAIL NATO Stock Numbers Related to 6505-01-313-1823 6505-01-581-3994 6505-01-074-0985
Usp Prochlorperazine Edisylate Injection Edisylate Injection Injection6505010740985 010740985 https
00-958-3403 https //www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-684-9630 Injection6505010740985 010740985
Usp Prochlorperazine Edisylate Injection 6505-00-684-9630 Injection6505010740985 010740985 https
Prochlorperazine Edisylate Injection 1610 https 6505-01-313-1823 6505-01-581-3994 https https 6505-01-074-0985
Restrictions 6505-01-074-0985
6505-01-074-0985 is a Usp Prochlorperazine Edisylate Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item has been determined to be hazardous and information is contained in the Hazardous Materials Information Resource System (HMIRS). The precious metals content of this item is unknown.
Import and Export 6505-01-074-0985
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-074-0985
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-074-0985
- Part Number
- Manufacturer
- Status
- NDC0007-3351-01
- Manufacturer
- 93544 - Glaxosmithkline Holdings (Americas) (Obsolete)
- Original Design
- Original Design
- COMPAZINE INJECTION
- 93544 - Glaxosmithkline Holdings (Americas) (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-074-0985
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 5.000 Milligrams Prochlorperazine Edisylate Per Milliliter
- Administration [CSGS]
- Intramuscular Or Intravenous
- Features Provided [CBBL]
- Sterile
- Primary Container Type [CQCT]
- Syringe With Needle
- Primary Container Content Quantity [CRLK]
- 2.000 Milliliters
- Pharmaceutical Vehicle Type [AKJQ]
- Aqueous
- Special Features [FEAT]
- Needle Size 22 Gage By 1-1/4 Inch; With 5 Mg. Sodium Biphosphate,12 Mg. Sodium Tartrate,0.9 Mg. Sodium Saccharin,And 0.75% Benzyl Alcohol
NATO Stock Numbers Related to 6505-01-074-0985
Freight Information 6505-01-074-0985
6505-01-074-0985 has freight characteristics.. 6505-01-074-0985 has a variance between NMFC and UFC when transported by rail and the description should be consulted.